February 2019 FDA Recall Drug by Akorn, Inc.
D-0993-2019 - Failed Impurities/Degradation Specifications

This Class II drug recall was voluntarily initiated by Akorn, Inc. on February 22, 2019 for the product Drug. The FDA reported the reason for recall as failed impurities/degradation specifications. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0993-2019

Reason for Recall
Failed Impurities/Degradation Specifications: High Out-of-Specification (OOS) results for Individual and Total Impurities that have been identified at the 18 months stability testing time point.
Initiated
02-22-2019
Reported
03-20-2019
Quantity
51,456 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Nationwide USA and Puerto Rico
Gentamicin Sulfate Ophthalmic Solution, USP, 0.3%, 5 mL bottle, Rx only, Manufactured for: Akorn, Inc., Lake Forest, IL 60045; NDC 17478-283-10.

Batch or Lot Expiration Information

Lot# Lot 7B71A, Exp 01/2020